Is post-COVID gut dysfunction the same as other dysbiosis?

Mechanistically it is read differently. In other dysbiosis the ecological shift is usually the entry point. After a viral illness, the plausible entry point is host-side: mitochondrial injury and reduced NAD+ availability in epithelial and endothelial cells, with the ecological shift following. This is an inference from the Host Capacity Model, not a validated clinical distinction.

How long does recovery take?

There is no defensible answer. BiomeLogic has no measured outcome dataset, and published post-viral recovery trajectories vary widely by cohort and by how recovery is defined. Anyone quoting a specific week count is quoting something that has not been measured in you.

What about NAD+ precursor supplementation?

NAD+ biology in post-viral states is an active research area. Human evidence for precursor supplementation changing gut-specific outcomes is limited and mostly indirect. This site does not publish dosing. Any supplementation decision belongs with a clinician who can see your full picture.

What if I have persistent stool SARS-CoV-2 RNA?

Viral persistence has been reported in stool after clinical recovery, and it is a reasonable reason to involve a clinician with post-viral expertise. Mechanistically, a persistent antigenic stimulus would keep the inflammatory input to the system running, which is why gut-directed work alone may not settle the picture.

Is post-viral GI dysfunction permanent?

Not by mechanism. Nothing in the bioenergetic account requires the state to be fixed. But the honest position is that trajectory varies, the drivers differ between people, and this site cannot predict an individual course.

How would I tell whether my gut symptoms are post-viral?

Temporal relationship is the main signal: onset within weeks to months of a documented infection, in someone without a prior GI history. Laboratory patterns reported in post-viral cohorts — shifts toward gram-negative dominance, reduced butyrate producers — are group-level findings, not individual diagnostic criteria.

How does this relate to the rest of post-viral syndrome?

Gut symptoms after a viral illness rarely appear alone. Fatigue, cognitive symptoms, and orthostatic intolerance frequently accompany them. The Host Capacity Model treats these as readouts from overlapping systems rather than separate diseases — a framing, not a demonstrated unifying diagnosis.

Condition framework

Post-COVID Gut Dysfunction: A Mechanistic Reading

Post-viral gut dysfunction read through mitochondrial injury, colonocyte bioenergetics, and barrier failure — with the evidence class stated for each step.

What is established

SARS-CoV-2 engages ACE2, which is expressed on enterocytes as well as respiratory epithelium. Gastrointestinal involvement during acute infection, and viral RNA detectable in stool after respiratory clearance, are both documented. Endothelial involvement is likewise well described. These are observations, not model-specific claims.

It is also established that colonocytes are unusual among epithelial cells in depending heavily on beta-oxidation of butyrate, and that this oxygen-consuming metabolism is what keeps the lumen anaerobic. When colonocyte energy metabolism is impaired, oxygen leaks into the lumen and facultative anaerobes — including many gram-negative Enterobacteriaceae — gain a competitive advantage. This oxygen-hypothesis account of dysbiosis is well supported in animal work and consistent with human observational data.

What is observed in human post-viral cohorts

Cohort studies have reported compositional shifts after COVID-19 — reduced abundance of butyrate-producing taxa such as Faecalibacterium and Roseburia, relative expansion of gram-negative organisms, and persistence of these shifts beyond clinical recovery in some participants. These are associations at group level. They do not establish that the compositional shift causes the symptoms, and they do not transfer to an individual stool report.

What the Host Capacity Model infers

The model's inference is about ordering. It proposes that the durable problem after a viral illness is reduced host capacity in the epithelial and endothelial compartments — impaired mitochondrial function and reduced NAD+ availability — and that the microbial picture is a downstream readout of that reduced capacity rather than an independent disease.

The mechanistic reasoning behind that inference: oxidative injury to the electron transport chain reduces colonocyte oxidative capacity; reduced oxidative capacity raises luminal oxygen; raised luminal oxygen shifts the community; the shifted community produces less butyrate, which is the colonocyte's preferred fuel. That is a self-sustaining loop, which is why the model predicts that treating the community without restoring host capacity produces temporary change.

This is a model-level inference. It has not been tested as a sequence in humans, and it is the part of this page most likely to be wrong.

What would falsify it

If post-viral gut symptoms resolved durably with community-directed intervention alone, while host bioenergetic markers stayed unchanged, the ordering claim would fail. If bioenergetic markers normalised without symptom change, it would fail from the other direction. Neither experiment has been done well enough in this population to settle the question.

Competing explanations worth taking seriously

Persistent viral antigen driving ongoing immune activation is a live alternative and does not require the bioenergetic account. Post-infectious neuroimmune changes in gut motility and visceral sensation — the mechanism invoked for post-infectious IBS after bacterial gastroenteritis — is another, with a longer evidence history. Autonomic dysfunction affecting motility is a third. These are not mutually exclusive with the model, and in any individual one of them may be doing most of the work.

What this page does not provide

No doses, no products, no prices, no staged week-by-week programme, and no recovery percentages. Earlier versions of this page carried all of those. They were removed because they presented unmeasured figures as if they were outcomes and read as clinical instruction rather than education. BiomeLogic does not diagnose, does not prescribe, and does not hold outcome data that could support such figures.

Frequently asked questions

Bring a case for mechanistic review.

Request a Consultation